Magle Chemoswed Holding AB (publ) (STO:MAGLE)
Sweden · Delayed Price · Currency is SEK 1.130
+0.130 (13.00%)
Jul 20, 2026, 5:20 PM CET
STO:MAGLE Market Cap
STO:MAGLE has a market cap or net worth of 30.26 million as of July 20, 2026. Its market cap has decreased by -94.36% in one year.
Market Cap
30.26M
Enterprise Value
386.42M
Revenue
273.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.13
ChartMarket Cap Chart
Since June 30, 2020, STO:MAGLE's market cap has decreased from 205.10M to 30.26M, a decrease of -85.24%. That is a compound annual growth rate of -27.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 30.26M | -91.67% |
| Dec 30, 2025 | 363.43M | -43.25% |
| Dec 30, 2024 | 640.39M | 135.30% |
| Dec 29, 2023 | 272.16M | -5.97% |
| Dec 30, 2022 | 289.44M | -10.37% |
| Dec 30, 2021 | 322.92M | -29.72% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AcouSort AB | 71.53M |
| Ascelia Pharma AB | 65.43M |
| Pila Pharma AB | 59.84M |
| 2cureX AB | 58.70M |
| Fluicell AB | 45.33M |
| Modus Therapeutics Holding AB | 44.64M |
| ExpreS2ion Biotech Holding AB | 33.96M |
| Guard Therapeutics International AB | 33.28M |